1. Fondi C, Franchi A. Definition of bone necrosis by the pathologist. Clin Cases Miner Bone Metab 2007;4:21–26.
2. Catto M. Pathology of aseptic bone necrosis. In: Davidson JK, ed. Aseptic necrosis of bone. Amsterdam: Excerpta Medica, 1976;3–100.
3. Phemister D. Necrotic bone and the subsequent changes which it undergoes. JAMA 1915;64:211–216.
4. Dubielzig RR, Biery DN, Brodey RS. Bone sarcomas associated with multifocal medullary bone infarction in dogs. J Am Vet Med Assoc 1981;179:64–68.
5. Marcellin-Little DJ, DeYoung DJ, Thrall DE, et al. Osteosarcoma at the site of bone infarction associated with total hip arthroplasty in a dog. Vet Surg 1999;28:54–60.
6. Riser WH, Brodey RS, Biery DN. Bone infarctions associated with malignant bone tumors in dogs. J Am Vet Med Assoc 1972;160:414–421.
7. Newman ME, Johnson KA. Suspected intramedullary bone infarct subsequent to tibial plateau levelling osteotomy in a dog. Aust Vet J 2015;93:255–258.
8. Haney DR, Peck JN. Influence of canal preparation depth on the incidence of femoral medullary infarction with Zurich Cementless Canine Total Hip arthroplasty. Vet Surg 2009;38:673–676.
9. Marsolais GS, Peck JN, Berry C, et al. Femoral medullary infarction prevalence with the Zurich Cementless Canine Total Hip arthroplasty. Vet Surg 2009;38:677–680.
10. Sebestyen P, Marcellin-Little DJ, DeYoung BA. Femoral medullary infarction secondary to canine total hip arthroplasty. Vet Surg 2000;29:227–236.
11. Fenger CK, Bertone JJ, Biller D, et al. Generalized medullary infarction of the long bones in a horse. J Am Vet Med Assoc 1993;202:621–623.
12. Martig S, Lippold BS, Oevermann A, et al. Polyostotic bone lesions consistent with bone infarction in a horse. Vet Rec 2008;162:352–353.
13. Sánchez J, Gonzalo-Orden JM, Ginja MMD, et al. Imaging diagnosis–medullary tibial infarction in a horse. Vet Radiol Ultrasound 2010;51:159–161.
14. Thrall DE. Textbook of veterinary diagnostic radiology. 6th ed. St Louis: Elsevier, 2013.
15. Rana RS, Wu JS, Eisenberg RL. Periosteal reaction. AJR Am J Roentgenol 2009;193:W259–W272.
16. Spodnick GJ, Berg J, Rand WM, et al. Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978–1988). J Am Vet Med Assoc 1992;200:995–999.
17. Anfinsen KP, Grotmol T, Bruland OS, et al. Breed-specific incidence rates of canine primary bone tumors–a population based survey of dogs in Norway. Can J Vet Res 2011;75:209–215.
18. Withrow SJ, Vail DM, Page RL. Withrow and MacEwen's small animal clinical oncology. 5th ed. St Louis: Elsevier, 2013.
19. Misdorp W, Hart AA. Some prognostic and epidemiologic factors in canine osteosarcoma. J Natl Cancer Inst 1979;62:537–545.
20. Ru G, Terracini B, Glickman LT. Host related risk factors for canine osteosarcoma. Vet J 1998;156:31–39.
21. Rosenberger JA, Pablo NV, Crawford PC. Prevalence of and intrinsic risk factors for appendicular osteosarcoma in dogs: 179 cases (1996–2005). J Am Vet Med Assoc 2007;231:1076–1080.
22. Baumgärtner W, Boyce RW, Alldinger S, et al. Metaphyseal bone lesions in young dogs with systemic canine distemper virus infection. Vet Microbiol 1995;44:201–209.
23. Bahk WJ, Lee AH, Kang YK, et al. Infarct associated sarcoma: a possible pathogenesis based on histological observation of repair tissue origin in two cases. Acta Oncol 2010;49:868–872.
24. Mirra JM. Secondary malignant fibrous histiocytoma (arising in bone infarcts). In: Mirra JM, Picci P, Gold RH, eds. Bone tumors: clinical, radiologic, and pathologic correlations. Philadelphia: Lea & Febiger, 1989.
Advertisement
To describe the radiographic appearance of benign bone infarcts and bone infarcts associated with neoplasia in dogs and determine the utility of radiography in differentiating benign and malignancy-associated bone infarcts.
49 dogs with benign (n = 33) or malignancy-associated (16) infarcts involving the appendicular skeleton.
A retrospective cohort study was performed by searching a referral osteopathology database for cases involving dogs with a histologic diagnosis of bone infarction. Case radiographs were anonymized and reviewed by 2 board-certified veterinary radiologists blinded to the histologic classification. Radiographic features commonly used to differentiate aggressive from nonaggressive osseous lesions were recorded, and reviewers classified each case as likely benign infarct, likely malignancy-associated infarct, or undistinguishable.
Only 16 (48%) of the benign infarcts and 6 (38%) of the malignancy-associated infarcts were correctly classified by both reviewers. Medullary lysis pattern and periosteal proliferation pattern were significantly associated with histologic classification. Although all 16 (100%) malignancy-associated lesions had aggressive medullary lysis, 23 of the 33 (70%) benign lesions also did. Eight of the 16 (50%) malignancy-associated infarcts had aggressive periosteal proliferation, compared with 7 of the 33 (21%) benign infarcts.
Results suggested that radiography was not particularly helpful in distinguishing benign from malignancy-associated bone infarcts in dogs.
Dr. Jones' present address is Pixel Veterinary Imaging, Austin, TX 78731.
Dr. Ruoff's present address is VitalRads, Cypress, TX 77410.